3,3',4'-trihydroxyflavone has been researched along with gossypetin in 2 studies
| Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (gossypetin) | Trials (gossypetin) | Recent Studies (post-2010) (gossypetin) |
|---|---|---|---|---|---|
| 39 | 0 | 22 | 49 | 0 | 33 |
| Protein | Taxonomy | 3,3',4'-trihydroxyflavone (IC50) | gossypetin (IC50) |
|---|---|---|---|
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 2.6 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 3 | |
| Sialidase | Clostridium perfringens | 0.8 | |
| Microtubule-associated protein tau | Homo sapiens (human) | 3 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 7.5 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 0.43 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 3.4565 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 7.5 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 0.33 | |
| 60 kDa chaperonin | Escherichia coli | 1.245 | |
| 10 kDa chaperonin | Escherichia coli | 1.245 | |
| Aurora kinase B | Homo sapiens (human) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eom, S; Hwang, DS; Hyun, J; Jo, G; Lee, Y; Lim, Y; Park, JC; Woo, Y | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
2 other study(ies) available for 3,3',4'-trihydroxyflavone and gossypetin
| Article | Year |
|---|---|
Relationships between structures of hydroxyflavones and their antioxidative effects.
Topics: Antioxidants; Flavones; Flavonoids; Flavonols; Free Radical Scavengers; Models, Molecular; Quantitative Structure-Activity Relationship | 2010 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |